Association Between Progesterone Level on Trigger Day to Basal Progesterone Ratio and in vitro Fertilization-Embryo Transfer Outcomes in Antagonist Protocols

拮抗剂方案中促排卵日孕酮水平与基础孕酮比值和体外受精-胚胎移植结局的相关性

阅读:2

Abstract

OBJECTIVE: To investigate the relationship between the progesterone level on trigger day (P(trigger)) to basal progesterone (bP) ratio and the outcomes of in vitro fertilization-embryo transfer (IVF-ET). METHODS: A retrospective analysis was conducted on women who received an antagonist protocol, with a P(trigger) less than 1.5 ng/mL and who underwent fresh embryo transfer. Based on the P(trigger)/bP ratio, participants were categorized into four groups: group A (P(trigger)/bP < 1, n = 284), group B (P(trigger)/bP ≥ 1 and < 2, n = 363), group C (P(trigger)/bP ≥ 2 and < 3, n = 165), and group D (P(trigger)/bP ≥ 3, n = 118). Recombinant follicle-stimulating hormone was used to stimulate ovulation. Receiver operating characteristic curve analysis was used to analyze the accuracy of the P(trigger)/bP ratio in predicting clinical pregnancy following fresh embryo transfer. RESULTS: A decreasing trend in bP levels was observed across groups (A > B > C > D), while P(trigger) levels showed an increasing trend (A < B < C < D). Groups A and B included significantly younger women and required lower doses of gonadotropin (Gn) compared to Groups C and D. The embryo implantation and clinical pregnancy rates in Group A were 34.93% and 49.30%, respectively, significantly higher than those in Group D (23.19% and 33.90%, respectively). After propensity score matching for age, the differences in implantation and clinical pregnancy rates were not statistically significant between Group A and D. The P(trigger/)bP ratio had limited accuracy in predicting clinical pregnancy, with an area under the curve of 0.538 (95% CI [confidence interval]: 0.501-0.575, P = 0.044). CONCLUSION: A P(trigger)/bP ratio of less than 1 was associated with relatively favorable pregnancy outcomes in women undergoing IVF-ET with an antagonist protocol for ovulation induction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。